Skip to main content
. 2013 Apr 25;49(1):31–37. doi: 10.4068/cmj.2013.49.1.31

Fig. 3.

Fig. 3

Percentage change in QUICKI and HOMA indices. The control and rosuvastatin treatment groups did not show significant changes in the QUICKI index (mean change, 2.2±11.6% vs. 3.6±11.9%; p=0.64) or the HOMA index (11.6±94.9% vs. 32.4±176.7%; p=0.44). QUICKI: Quantitative Insulin-Sensitivity Check Index, HOMA: Homeostasis Model Assessment.